Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 332

Results For "C"

9210 News Found

DPIIT recognises 1, 17,254 startups as on Dec 2023
Startup | February 03, 2024

DPIIT recognises 1, 17,254 startups as on Dec 2023

At least one recognised startup in every State and UT; spread across over 80% of districts


Abbott India posts Q3 FY24 PAT at Rs. 310.98 Cr
News | February 03, 2024

Abbott India posts Q3 FY24 PAT at Rs. 310.98 Cr

Abbott India has reported total income of Rs. 1492.75 crores during the period ended December 31, 2023


Thyrocare Technologies posts Q3 FY24 consolidated PAT at Rs. 15.35 Cr
News | February 03, 2024

Thyrocare Technologies posts Q3 FY24 consolidated PAT at Rs. 15.35 Cr

Thyrocare Technologies has reported total income of Rs. 137.47 crores during the period ended December 31, 2023


Dr Lal Path Labs posts Q3 FY24 consolidated PAT at Rs. 81.3 Cr
News | February 03, 2024

Dr Lal Path Labs posts Q3 FY24 consolidated PAT at Rs. 81.3 Cr

Dr. Lal Path Labs has reported total income of Rs. 557.2 crores during the period ended December 31, 2023


GMM Pfaudler posts Q3 FY24 consolidated PAT at Rs. 31.72 Cr
News | February 03, 2024

GMM Pfaudler posts Q3 FY24 consolidated PAT at Rs. 31.72 Cr

GMM Pfaudler has reported total income of Rs. 848.28 crores during the period ended December 31, 2023


Industry’s reaction to Union Budget 2024-25
Policy | February 02, 2024

Industry’s reaction to Union Budget 2024-25

Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry


Max Healthcare Institute Ltd Q3 FY24 consolidated profit up at Rs. 289.34 Cr
News | February 02, 2024

Max Healthcare Institute Ltd Q3 FY24 consolidated profit up at Rs. 289.34 Cr

Max Healthcare Institute has reported total income of Rs. 1380.99 crores during the period ended December 31, 2023


Dabur India posts Q3 FY24 consolidated PAT at Rs. 514.22 Cr
News | February 02, 2024

Dabur India posts Q3 FY24 consolidated PAT at Rs. 514.22 Cr

Dabur India has reported total income of Rs. 3382.43 crores during the period ended December 31, 2023


Vimta Labs posts Q3 FY24 consolidated PAT at Rs. 10.13 Cr
News | February 02, 2024

Vimta Labs posts Q3 FY24 consolidated PAT at Rs. 10.13 Cr

Vimta Labs has reported total income of Rs. 82.57 crores during the period ended December 31, 2023


Morepen Laboratories reports Q3 FY24 consolidated PAT at Rs. 31.99 Cr
News | February 02, 2024

Morepen Laboratories reports Q3 FY24 consolidated PAT at Rs. 31.99 Cr

Morepen Laboratories has reported total income of Rs. 448.62 crores during the period ended December 31, 2023